Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Karyotyping01:17

Karyotyping

69.9K
Overview
69.9K
Genetic Screens02:46

Genetic Screens

5.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum-derived albumin as a cryoprotective agent for the long-term storage of red blood cells: A preliminary examination.

Transfusion·2026
Same author

Exploring tricine as a novel red cell cryopreservative: Lessons and future directions.

Vox sanguinis·2025
Same author

RHCE genotyping using next generation sequencing: Allele specific reference sequences.

Transfusion·2024
Same author

Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort.

Obstetrics and gynecology·2024
Same author

Investigation of Wright Blood Group Alleles and Genotypes in Malaria-Endemic Area in Southwestern Saudi Arabia.

International journal of general medicine·2024
Same author

Lysophosphatidylcholine Acetyltransferase 2 (<i>LPCAT2</i>) Influences the Gene Expression of the Lipopolysaccharide Receptor Complex in Infected RAW264.7 Macrophages, Depending on the <i>E. coli</i> Lipopolysaccharide Serotype.

Biology·2024

Related Experiment Video

Updated: Mar 26, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

1.1K

Non-Invasive Screening Tools for Down's Syndrome: A Review.

Kelly A Sillence1, Tracey E Madgett2, Llinos A Roberts3

  • 1School of Biomedical and Biological Sciences, Plymouth University Peninsula School of Medicine and Dentistry, Plymouth University, Plymouth, PL4 8AA, UK. kelly.sillence@plymouth.ac.uk.

Diagnostics (Basel, Switzerland)
|February 3, 2016
PubMed
Summary

Non-invasive prenatal diagnosis using next-generation sequencing shows promise for detecting Down's syndrome (DS). Further validation is needed before widespread clinical use, but advancements improve screening accuracy.

Keywords:
Down’s syndromebiomarkersnext-generation-sequencingnon-invasivescreeningsonographic markers

More Related Videos

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

38.0K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.6K

Related Experiment Videos

Last Updated: Mar 26, 2026

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
06:38

In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells

Published on: March 7, 2025

1.1K
FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

38.0K
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.6K

Area of Science:

  • Genetics
  • Prenatal Diagnostics
  • Bioinformatics

Background:

  • Down's syndrome (DS) is a leading cause of developmental delay, frequently prompting invasive prenatal diagnostic procedures.
  • Invasive prenatal tests carry a small but significant risk of miscarriage, driving the demand for safer alternatives.
  • Current prenatal screening is the primary method for detecting fetal aneuploidy, though it does not provide a diagnosis.

Purpose of the Study:

  • To review the evolution of prenatal screening for Down's syndrome.
  • To discuss the potential of next-generation sequencing (NGS) for non-invasive prenatal diagnosis (NIPD).
  • To explore advancements in screening markers utilizing proteomic and bioinformatic approaches.

Main Methods:

  • Review of historical and recent developments in prenatal screening strategies.
  • Discussion of next-generation sequencing (NGS) technologies for non-invasive prenatal diagnosis (NIPD).
  • Analysis of novel screening markers derived from proteomic and bioinformatic techniques.

Main Results:

  • Next-generation sequencing (NGS) represents a significant advancement in non-invasive prenatal diagnosis (NIPD) for Down's syndrome.
  • While NIPD for DS is not yet clinically standard, ongoing validation studies are crucial for low-risk pregnancies.
  • Improved screening programs enhance detection rates, potentially reducing the need for invasive procedures.

Conclusions:

  • Prenatal screening has evolved from maternal age-based assessment to incorporating advanced markers.
  • Non-invasive prenatal diagnosis (NIPD) via NGS offers a promising, safer alternative to invasive testing for fetal aneuploidies like Down's syndrome.
  • Continued research in proteomic and bioinformatic techniques is vital for refining prenatal screening accuracy and patient care.